Clifford Chance instructed by Pfizer on CMA competition law row
Clifford Chance is advising pharmaceutical company Pfizer on allegations made by the Competition and Markets Authority (CMA) that it charged “excessive” prices for an anti-epilepsy drug. The CMA investigation into sales of the drug Phenytin Sodium to the NHS by Pfizer and Flynn Pharma was announced on Thursday (6 August). The organisation has accused the […]